VCAN and central nervous system cancer: Unlike our previous study showing syndecan 1 to be the main VAR2CSA receptor in the placental syncytium [55], we found several interesting hits on the glioma cell lines, including syndicans, glypicans, neuropilins, decorin, versican, CSPG4, and PTPRZ1.